Robert Nicol

Robert Nicol is a highly accomplished biotechnology entrepreneur and scientific leader, currently serving as President and Scientific Co-Founder of Skyhook, which focuses on innovative biomolecule discovery platforms. As a Scientific Co-Founder of Synolo Therapeutics, Robert is advancing precision-targeted immunotherapies for cancer using cutting-edge technologies. In addition, Robert holds the position of Venture Partner at RA Capital Management, creating new biotechnology ventures. With a strong background at HiFiBiO Therapeutics and a distinguished tenure at the Broad Institute, where Robert directed significant technology development initiatives, Robert has made significant contributions to fields including synthetic biology and high-throughput sequencing. Robert's educational background includes a PhD in Engineering Systems and dual Master's degrees in Chemical Engineering and Business Administration from the Massachusetts Institute of Technology, along with a Bachelor's degree in Mechanical Engineering from the University of Houston.